Lipid composition of erythrocytes at cardiovascular and hepatobiliary diseases

Lipids: Categories, Biological Functions and Metabolism, Nutrition and Health

Volumn , Issue , 2011, Pages 1-44

  Zhukova, Natalia V ^a   Novgorodtseva, Tatyana P ^b  

^a INSTITUTE OF MARINE BIOLOGY   (Russian Federation)

^b INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881142914     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (105)

1. Abdel-Ghaffar, TY; Amin, M; Rasheed, MA; Fouad, HH. Essential fatty acids status in infants and children with chronic liver disease. J Clin Biochem Nutr, 2003 33, 1-6.
2. Adams, PB; Lawson, S; Sanigorski, A; Sinclair, AJ. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids, 1996 31, 157-161.
3. Al, MD; Badart-Smook A; von Houwelingen, AC et al. Fat intake of women during normal pregnancy: relationship with maternal and neonatal essential fatty acid status. J Am Coll Nutr, 1996 15, 49-55.
4. Albert, CM; Campos, H; Stampfer, MJ. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med, 2002 346, 1113-1118.
5. Anderson, BM; Ma, DWL. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis, 2009 8, 33
6. Andoh, T; Yoshimitsu, M; Hatano, H. et al. The differences in cord-blood cholesterol and fatty acid levels among Japanese fetuses. J. Epidemiol. 1997 7, 226-231.
7. Antoku, Y; Tsukamoto, K; Miyoshi, Y; Nagino, H; Anezaki, M; Suwa, K; Narabe, Y. Correlations of elevated levels of hexacosanoate in erythrocyte membranes with risk factors for atherosclerosis. Atherosclerosis, 2000 153, 169-173.
8. Arranz, MI; Lasuncion, MA;, Perales, J; Herrera, E; Lorenzo, I; Carcamo, C; Concostrina, L; Villar, J; Gasalla, R. Fatty acid composition of lipoprotein lipids in hepatobiliary diseases. Eur J Clin Chem Clin Biochem, 1996 34, 701-709.
9. Bagga, D; Capone, S; Wang, HJ; Heber, D; Lill, M; Chap, L; Glaspy, JA. Dietary modulation of omega-3/omega-6 polyunsaturated fatty acid ratios in patients with breast cancer. J. Natl. Canc. Inst. 1997 89, 1123-1131.
10. Bjerve, KS; Fougner, KJ; Midthjell, K; Bobao, K. N-3 fatty acids in old age. J. Intern. Med. Suppl. 1989 225, 191-196.
11. Block, RC; Harris, WS; Reid, KJ; Sands, SA; Spertus, JA. EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008 197, 821-828.
12. BoltonSmith, C; Woodward, M; Tavendale, R. Evidence for age-related differences in the fatty acid composition of human adipose tissue, independent of diet. Eur J Clin Nutr, 1997 51, 619-624.
13. Boulton, TJC; Magarey, AM; Cockington, RA. Serum lipids and apolipoprotiens from 1 to 15 years: changes with age and puberty, and relationships with diet, parental cholesterol and family history of ischaemic heart disease. Acta Pediatrica. 1995 84, 1113-1118.
14. Buchwald, H; Menchaca, HJ;. Michalek, VN; Rohde, TD; Buchwald, DB; Hunninghake, HJ; O'Dea TJ. Plasma cholesterol: an influencing factor in red blood cell oxygen release and cellular oxygen availability. J. Am. Coll. Surg. 2000 191, 490-497.
15. Caggiula, AW; Mustad, VA. Effects of dietary fat and fatty acids on coronary artery disease risk and total and lipoprotein cholesterol concentrations: epidemiologic studies. Am. J. Clin. Nutr. 1997 65, 1597S-1610S.
16. Calder, PC. Polyunsaturated fatty acids, inflammation, and immunity. Lipids 2001 36, 1007-1024.
17. Chapkin, RS; Seo, JM; McMurray; DN, Lupton, JR. Mechanisms by which docosahexaenoic acid and related fatty acids reduce colon cancer risk and inflammatory disorders of the intestine. Chem Phys Lipids, 2008 153, 14-23.
18. Cooper, RA. Lipids of human red cell membrane: normal composition and variability in disease. Semin. Hematol., 1970 7, 296-322.
19. Das, UN. Essential fatty acid metabolism in patients with essential hypertension, diabetes mellitus and coronary heart disease. Prostaglandins, Leukotrienes and Essential Fatty Acids, 1995 53, 387-391.
20. Decsi, T; Kolechko, B. Fatty-acid composition of plasma-lipid classes in healthy-subjects from birth to young adulthood. Eur J Pediatr, 1994 153, 520-525.
21. Decsi, T; Kolechko, B. Role of long-chain polyunsaturated fatty acids in early human neurodevelopment. Nutr. Neurosc, 2000 3, 293-306.
22. Devaux, PF; Herrmann, A; Ohlwein; N, Koziov, MM. How lipid flippases can modulate membrane structure. Biochim Biophys Acta-Biomembranes, 2008 1778, 1591-1600.
23. Dewailly, E; Blanchet, C; Lemieux, S. N-3 fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am J Clin Nutr, 2001 74, 464-73.
24. Endakova, EA; Novgorodtseva, TP; Svetashev, VI. Modification of blood fatty acid composition in case of cardio-vascular diseases. Vladivostok: Dalnauka; 2002.
25. Fekete, K; Marosvolgyi, T; Jakobik, V; Decsi, T. Methods of assessment of n-3 long-chain polyunsaturated fatty acid status in humans: a systematic review. Am J Clin Nutr, 2009 89, 2070S-2084S.
26. Fenton, WS; Hibbeln, J; Knable, M. Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia. Biol Psychiat, 2000 47, 8-21.
27. Galland, L. Increased requirements for essential fatty acids in atopic individuals: a review with clinical descriptions. J Am Coll Nutr, 1986 5, 213-228.
28. Gerique, JAG; Porres, A; Martinez, DL; et al. Levels of lipoprotein and plasma lipids in Spanish children aged from 4 to 18 years. Acta Pediatrica, 1996 85, 38-42.
29. Gibson, RA; Sinclair, AJ. Are Eskimos obligate carnivores? Lancet, 1981 1, 1100.
30. Guerra, A; Demmelmair, H; Toschke, AM; Koletzko. B. Three-year tracking of fatty acid composition of plasma phospholipids in healthy children. Ann Nutr Metab, 2007 51, 433-438.
31. Harris, WS. The omega-3 index as a risk factor for coronary heart disease Am J Clin Nutr, 2008 87, 1997S-2002S.
32. Harris, WS; Sands, SA; Windsor, SL; et al. Omega-3 fatty acids in cardiac biopsies from heart transplant patients: correlation with erythrocytes and response to supplementation. Circulation, 2004 110, 1645-1649.
33. Harris, WS; von Schacky, C. The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev Med, 2004 39, 212-220.
34. Harwood, JL. Lipid metabolism. In: Gunstone, FD; Harwood JL; Padzey, FB., editors. The Lipid Handbook. London, Glasgow, New York, Tokyo, Melbourne, Madras; 1994; 605-633.
35. Hashimoto, M; Hossain, S; Shido, O. Docosahexaenoic acid but not eicosapentaenoic acid withstands dietary cholesterol-induced decreases in platelet membrane fluidity. Mol Cell Biochem, 2006 293, 1-8.
36. Hegele, RS. Genetic variation of intestinal fatty acid-binding protein associatioed with variation in body mass in aboriginal Canadians. J. Clin. Endocrinol. Metab, 1996 81, 4334-4337.
37. Hoffman, DR; Birch, EE; Birch DG; et al. Effect of supplementation with ω-3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants. Am. J. Clin. Nutr, 1993 57, 807S-812S.
38. Horrobin, DF. Low prevalences of coronary heart disease (CHD), psoriasis, astma and rheumatoid arthritis in Eskimos: are they cause by high dietaryintake of eicosapentaenoic acid (EPA), a genetic variation of essential fatty acid (EFA) metabolism or a combination of both? Med. Hypoth., 1987 22, 421-428.
39. Horton, TJ; Commerford, SR; Pagliassotti, MJ; Bessesen, DH. Postprandial leg uptake of triglyceride is greater in women than in men. Am. J. Physiol. Endocrinol. Metab., 2002 283, E1192-1202.
40. Innis,SM; Owens, SD. Dietary fatty acid composition in pregnancy alters neurite membrane fatty acids and dopamine in newborn rat brain. J Nutr, 2001 131, 118-122.
41. Jakobik, V; Burus, I; Decsi, T. Fatty acid composition of erythrocyte membrane lipids in healthy subjects from birth to young adulthood. Eur J Pediatr, 2009 168, 141-147.
42. Jensen, MD; Cryer, PE; Johnson, CM; Murray, MJ. Effects of epinephrine on regional free fatty acid and energy metabolism in men and women. Am. J. Phisiol., 1996 270, E259-264.
43. Kabagambe, EK; Tsai, MY; Hopkins, PN; Ordovas, JM; Peacock, JM; Boreck, IB; Arnett, DK. Erythrocyte fatty acid composition and the metabolic syndrome: a national heart, lung, and blood institute GOLDN study. Clin Chem, 2008 54, 154-162.
44. Karpe, F. Mechanisms of postprandial hyperlididemia-remnants and coronary artery disease. Diabet Med., 1997 14, S60-66.
45. Klimov, AN; Nagorvev, VA. Mechanism of lipoprotein penetration into the arterial-wall leading to development of atherosclerosis. Atherosclerosis Reviews, 1983 11, 107-156.
46. Knuth, ND; Horowitz, JF. The elevation of ingested lipids within plasma chylomicrons is prolonged in men compared with women. J Nutr, 2006 136, 1498-1503.
47. Krachler, B; Norberg, M; Eriksson, JW; Hallmans, G; Johansson, I; Vessby, B; Weinehall, L; Lindahl, B. Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. Nutrit Metab Cardiovas, 2008 18, 503-510.
48. Krause, C; Rosewich, H; Gartner, J. Rational diagnostic strategy for Zellweger syndrome spectrum patients. Eur J Hum Genet, 2009 17, 741-748.
49. Lambert, J; Agostoni, C; Elmadfa, I; Hulshof, K; Krause, E;, Livingstone, B; Socha, P; Pannemans, D; Samartin, S. Dietary intake and nutritional status of children and adolescents in Europe. Brit J Nutr, 2004 92, S147-S211.
50. Lausada, NR; Boullon, S; Boullon, F; De Gomez Dumm, IN. Erythrocyte membrane, plasma and atherosclerotic plaque lipid pattern in coronary heart disease. Medicina-Buenos Aire, 2007 67, 451-457.
51. Lebedeva, EN. Dislipidemia and hypovitaminosis in children of school age. PhD thesis. 1994.
52. Lemaitre, RN; King, IB; Raghunathan, TE; et al. Cell membrane trans-fatty acids and the risk of primary cardiac arrest. Circulation, 2002 105, 697-701.
53. Levant, B; Ozias, MK; Carlson, SE. Diet (n-3) polyunsaturated fatty acid content and parity affect liver and erythrocyte phospholipid fatty acid composition in female rats. J. Nutr. 2007 137, 2425-2430.
54. Levy, E; Brunet, S; Alvarez, F; Seidman, E; Bouchard, G; Escobar, E; Martin, S. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease. Life Scis, 2007 80, 1472-1483.
55. Magkos, F; Mittendorfer, B. Gender differences in lipid metabolism and the effect of obesity. Obstet Gyn Clin N Am, 2009 36, 245-254.
56. Malinska, H; Oliyarnyk, O; Hubova, M; Zidek, V; Landa, V; Simakova, M; Mlejnek, P; Kazdova, L; Kurtz, TW; Pravenec, M. Increased liver oxidative stress and altered PUFA metabolism precede development of non-alcoholic steatohepatitis in SREBP-1a transgenic spontaneously hypertensive rats with genetic predisposition to hepatic steatosis. Mol Cell. Biochem., 2009 In press.
57. Minda, H; Larque, E; Koletzko, B; Decsi, T. Systematic review of fatty acid composition of plasma phospholipids of venous cord blood in full-term infants. Eur J Nutr, 2002 41, 125-131.
58. Montagne, CT; O'Rahilly, S. The perils of portliness-Causes and consequences of visceral adiposity. Diabetes, 2000 49, 883-888.
59. Nagao, K; Yanagita, T. Conjugated fatty acids in food and their health benefits. J. Biosci. Bioeng, 2005 100, 152-157.
60. Nettleton, J.A. Omega-3 fatty acids and health. New York: Chapman and Hall; 1995.
61. Nijs, J; De Meirleir, K. Oxidative stress might reduce essential fatty acids in erythrocyte membranes of chronic fatigue syndrome patients. Nutr Neurosci, 2004 7, 251-253.
62. Novgorodtseva, TP. Erythrocyte phospholipids at development of coronary heart disease. The Bull of Siberian Branch of RAMS. 1998 1, 15-18.
63. Novgorodtseva, TP; Abakumov, AI; Sorokina, LV. Multidimensional statistic metods and the diagnostic significance of erythrocyte fatty acids in cardiovascular diseases. Klin. Lab. Diag., 2001 3, 13-16.
64. Novgorodtseva, TP; Ivanov, EM; Antoniuk, MV; Kamanan, YK; Zhukova, NV; Yurenko, AV. Non-esterified fatty acid composition in patients with metabolic syndrome. Klin. Lab. Diag, 2008 10, 38-40.
65. Novgorodtseva, TP; Kamanan, YK; Antoniuk, MV; Zhukova, NV. Modification of free and esterified fatty acids under metabolic syndrome. Klinical Medicine, 2009 5, 33-37.
66. Novgorodtseva, TP; Svetashev, VI; Zhukova, NV. Ontogenetic regularities of phospholipid pool formation of rat erythrocyte membranes at normal and heart pathology development. Proceedings of Institute of Medical Climatology and Rehabilitative Treatment. Vladivostok: Dalnauka; 2004; 78-87.
67. Novgorodtseva, TP; Viazova, AV; Zhukova, VV. Membrane lipids of patients with chronic bronchitis associated with urolithiasis in phase of clinical remission. Klin. Lab. Diag., 2006 2, 7-9.
68. Novgorodtseva, TP; Zhuravskaya, NS; Vostrikova, O.G. Blood lipids in offsprihgs of patients with ischemic heart disease. Kardiologiia, 2002 42, 32-37.
69. Pala, V; Krogh, V; Muti, P; Chajes, V; Riboli, E; Micheli, A; Saadatian, M; Sieri,S; Berrino F. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J. Natl. Cancer Inst., 2001 93, 1088-95.
70. Peterson, DB; Fisher, K; Carter RD; Mann, N. Fatty acid composition of erythrocytes and plasma triglyceride and cardiovascular risk in Asian diabetic patients. Lancet, 1994 342, 1528-1530.
71. Pettei, MJ; Daftary, S; Levine, JJ. Essential fatty-acid deficiency associated with the use of a medium-chain-triglyceride infant formula in pediatric hepatobiliary disease. Am J Clin Nutr, 1991 53, 1217-1221.
72. Poppitt S.D., Kilmartin P., Butler P., Keogh G.F. Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial. Lipids Health Dis, 2005 4. P. 30-37.
73. Rajeshwari, R; Nicklas, TA; Pownall, HJ; Berenson, GS. Cardiovascular diseases -a major health risk in Asian Indians. Nutr Res, 2005 25, 515-533.
74. Ricci, S; Patoia, L, Berretini, M. et al. Fatty acid pattern of red blood cell membranes and risk of ischemic brain infarction-a case-control study. Stroke, 1987 18, 575-578.
75. Robberecht, E; Koletzko, B; Christophe, A. Several mechanisms contribute to the abnormal fatty acid composition of serum phospholipids and cholesterol esters in cholestatic children with extrahepatic biliary atresia. Prostaglandins Leukotrienes and Essential Fatty Acids, 1997 56 199-204.
76. Rosseneu, M. Cambien, F; Vinaimont, N; Nicaud, V; Debacker, G. Biomarkers of dietary-fat composition in young-adults with a parental history of premature coronary heart-disease compared with controls -the ears study. Atherosclerosis, 1994 108, 127-136.
77. Salem, N.Jr.; Niebylski, CD. The nervous system has an absolute molecular species requirement for proper function. Mol. Membr. Biol., 1995 12, 131-134.
78. Sands, SA; Reid, KJ; Windsor, SL; Harris, WS. The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids, 2005 40, 343-347
79. Shamir, R; Tershakovec, AM; Gallagher, PR;, Liacouras, CA; Hayman, LL; Cortner, JA. The influence of age and relative weight on the presentation of familial combined hyperlipidemia in childhood. Atherosclerosis, 1996 121, 85-91.
80. Shestopalov, EY; Novgorodtseva, TP; Kamanan, YK; Antoniuk, MV; Zhukova, NV. Status of lipid components of the erythrocyte membranes in patients with comorbidities of viscera. Bull Siberian Br Rus Acad Med Sci, 2009 135, 32-37.
81. Simopoulos, AP. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases Exp Biol Med, 2008 233, 674-88.
82. Socha, P; Koletzko B, Pawlowska, J; Socha, J. Essential fatty acid status in children with cholestasis, in relation to serum bilirubin concentration. J Pediatr, 1997a 131, 700-706.
83. Socha, P; Koletzko, B; Jankowaka, I; Pawlowska, J; Demmelmair, H; Swiatkowska, E; Socha, J. Long-chain PUFA supplementation improves PUFA profile in infants with cholestasis. Lipids, 2002 37, 953-957.
84. Socha, P; Koletzko, B; Pawlowska, J; Proszynska, K; Socha, J. Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): Effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids. J Pediatr Gastr Nutr, 1997b 24, 189-193.
85. Socha, P; Koletzko,B; Swiatkowska, E; Pawlowska, J; Stolarczyk, A; Socha, J. Essential fatty acid metabolism in infants with cholestasis. Acta Paediatr, 1998 87, 278-283.
86. Sumida, W; Kaneko, K; Ono, Y; Tainaka, T; Ando, H. Different polyunsaturated fatty acid profiles in patients with biliary atresia after successful Kasai operation and liver transplantation. Pediatr Surg Int, 2009 25, 255-259.
87. Sumner, AE; Farmer, NM; Tulloch-Reid, MK; Sebring, NG; Yanovski, JA; Reynolds, JC; Boston, RC; Premkumar, A. Sex differences in visceral adipose tissue volume among African Americans, Am. J. Clin. Nutr. 2002 76, 975-979.
88. Sumner, AE; Kushner, H; Tulenko, TN; Falkner, B; Marsh, JB. The relationship in African-Americans of sex differences in insulin-mediated suppression of nonesterified fatty acids to sex differences in fasting triglyceride levels. Metabolism, 1997 46, 400-405.
89. Sun, Q; Ma, J; Campos, H; Hankinson, SE; Hu, FB. Comparison between plasma and erythrocyte fatty acid content as biomarkers of fatty acid intake in US women. Am J Clin Nutr, 2007 86, 74-81.
90. Takamatsu, H; Noguchi, H; Tahara, H; Kaji, T; Shimono, R; Ikee, T; Andoh, T. Plasma fatty acids concentrations in postoperative patients with biliary atresia. Nutrition, 1999 15, 755-759
91. Taus, M; Dousset, N; Moreau, J; Ferretti, G; Galeazzi, T; Solera, ML; Curatola, G; Valdiguie, P. Study of fluidity of low density lipoproteins from liver cirrhotic patients. Nutr Metab Cardiovasc, 1999 9, 289-293.
92. Theret, N; Bard, JM; Nuttens, MC et al. The relationship between the phospholipid fatty acid composition of the red blood cells, plasma, lipids and apolipiprotiens. Metabolism, 1993 42, 562-568.
93. Titov, VN. Blockade of saturated fatty acids transport to a cell: Pathogenesis of essential hypertension. Voprosy Meditsinskoi Khimii, 1998 44 317-330.
94. Tsukanov, VV; Kuperstein, EY; Tonkikh, YL; Bronnikova, EP. Association of fatty acid composition of blood serum with bile lipid composition in cholelithiasis patients. Terapevticheskii Arkhiv, 2008, 80, 71-75.
95. Tziomalos K;, Weerasinghe, CN; Mikhailidis, DP; Seifalian, AM. Vascular risk factors in South Asians. Int J Cardiol, 2008 128, 5-16.
96. Uauy, R; Hoffman, DR; Mena, P; Llanos, A; Birch, EE. Term infant studies of DHA and ARA supplementation on neurodevelopment: results of randomized controlled trials. J Pediatr, 2003 143, 17-25.
97. van Wezel-Meijler, G; van der Knaap, MS; Huisman, J; Jonkman, EJ; Valk, J; Lafeber, HN. Dietary supplementation of long-chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturation. Acta Paediatr, 2002 91 942-950.
98. Vostrikova, OG; Slezka, IE. Status of lipid metabolis in children population of South of Primorye region. Human Physiology, 1999 3, 132-137.
99. Warensjo, E; Ohrvall, M; Vessby, B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr Metab Cardiovasc, 2006 16, 128-136.
100. Williams, CM. Lipid metabolism in women. P Nutr Soc, 2004 63, 153-160.
101. Wolfs, JLN; Comfurius, P; Bekers, O; Zwaal, RFA; Balasubramanian, K; Schroit; AJ, Lindhout, T; Bevers, EM. Direct inhibition of phospholipid scrambling activity in erythrocytes by potassium ions. Cell Mol Life Sci, 2009. 66, 314-323.
102. Yamaji-Hasegawa, A; Tsujimoto, M. Asymmetric distribution of phospholipids in biomembranes. Biol Pharm Bull, 2006, 29, 1547-1553.
103. Yamashiro, Y; Shimizu, T; Ohtsuka, Y; Nittono, H; Miyano, T; Kawakami, S; Hayasawa, H. Docosahexaenoic acid status of patients with extrahepatic biliary atresia. J Pediatr Surg, 1994 29, 1455-1458.
104. Zappalla, FR; Gidding, SS. Lipid Management in Children. Endocrin Metab Clin, 2009 38, 171-184.
105. Zeh, N; Rossi, SS; Hofmann, AF; Steinbach, JH; Hagey, LR; Oliver, D; Stange, J; Hassanein, T. The effect of extracorporeal albumin dialysis on plasma phospholipid fatty acids in patients with end-stage liver disease. Liv Inter, 2003 23, 34-38.